In the BioHarmony Drug Report Database

"Preview" Icon

Insulin lispro

Admelog, Humalog, Liprolog, Liumjev, Lyumjev (insulin lispro) is a protein pharmaceutical. Insulin lispro was first approved as Admelog on 1996-04-30. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.

 

Trade Name

 

Humalog, Liprolog, Liumjev, Lyumjev
 

Common Name

 

insulin lispro
 

ChEMBL ID

 

CHEMBL1201538
 

Indication

 

diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus
 

Drug Class

 

Image (chem structure or protein)

Insulin lispro structure rendering